Arterosil, a patent-pending nutraceutical, is the only product in the world that has been clinically proven to rebuild the endothelial glycocalyx. Arterosil contains specialized sulfated polysaccharides (SSP) derived from a rare seaweed and are reported to possess anticoagulant and antithrombotic activity.
Strengthens the artery wall's protective barrier
Promotes a healthy heart
Maintains a healthy artery wall
Supports a strong and vital glycocalyx